← Back to Patent Explorer
US2761807A Expired / Lapsed US ⏱️ 0.0 years remaining

Glycocyamine and methylating agent in vivo creatine producing composition

Assignee: California Institute Research Foundation
•
Filing: 1955-05-16
•
Granted: 1956-09-04
•
Expires: 1975-05-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

No abstract record available.

Inventors

  • 👤 Borsook Henry
  • 👤 Mannie E Borsook

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 17:26
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19; A61K31/195; A61K31/205

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 129 words
A THERAPEUTIC COMPOSITION, WHICH PRODUCES CREATINE IN VIVO IN THE HUMAN BODY, SAID COMPOSITION BEING EFFECTIVE IN THE TREATMENT OF DISEASED AND WEAK MUSCLE TISSUES IN A DOSAGE OF THE ESSENTIAL THERAPEUTICALLY ACTIVE INGREDIENTS INCLUDING GLYCOCYAMINE PROVIDING ABOUT 30 MILLIGRAMS OF GLYCOCYAMINE PROVIDING ABOUT 30 MILLISAID COMPOSITION CONTAINING AS ESSENTIAL THERAPEUTICALLY ACTIVE INGREDIENTS GLYCOCYAMINE AND FROM THREE TO ABOUT FIVE MOLS PER MOL OF GLYCOCYANINE OF A MATERIAL SELECTED FROM THE GROUP CONSISTING OF BETAINE, BETAINE HYDRATE, CHOLINE AND DIMETHYLTHETIN, SAID GLYCOCYAMINE BEING PRESENT IN SAID COMPOSITION PREDOMINANTLY AS A SOLID, THE CONCENTRATION OF SAID GLYCOCYAMINE AND SAID MATERIAL IN SAID COMPOSITION BEING SUCH THAT SAID COMPOSITION CAN BE THERAPEUTICALLY ADMINISTERED IN THE AMOUNT REQUISITE TO PROVIDE ABOUT 30 MILLIGRAMS OF GLYCOCYAMINE PER POUND OF BODY WEIGHT PER DAY.
Claim 2
Dependent Claim 129 words
A THERAPEUTIC COMPOSITION, WHICH PRODUCES CREATINE IN VIVO IN THE HUMAN BODY, SAID COMPOSITION BEING EFFECTIVE IN THE TREATMENT OF DISEASED AND WEAK MUSCLE TISSUES IN A DOSAGE OF THE ESSENTIAL THERAPEUTICALLY ACTIVE INGREDIENTS INCLUDING GLYCOCYAMINE PROVIDING ABOUT 30 MILLIGRAMS OF GLYCOCYAMINE PROVIDING ABOUT 30 MILLISAID COMPOSITION CONTAINING AS ESSENTIAL THERAPEUTICALLY ACTIVE INGREDIENTS GLYCOCYAMINE AND FROM THREE TO ABOUT FIVE MOLS PER MOL OF GLYCOCYANINE OF A MATERIAL SELECTED FROM THE GROUP CONSISTING OF BETAINE, BETAINE HYDRATE, CHOLINE AND DIMETHYLTHETIN, SAID GLYCOCYAMINE BEING PRESENT IN SAID COMPOSITION PREDOMINANTLY AS A SOLID, THE CONCENTRATION OF SAID GLYCOCYAMINE AND SAID MATERIAL IN SAID COMPOSITION BEING SUCH THAT SAID COMPOSITION CAN BE THERAPEUTICALLY ADMINISTERED IN THE AMOUNT REQUISITE TO PROVIDE ABOUT 30 MILLIGRAMS OF GLYCOCYAMINE PER POUND OF BODY WEIGHT PER DAY.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1959-09-04 1960-03-05 1960-09-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1963-09-04 1964-03-05 1964-09-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1967-09-04 1968-03-05 1968-09-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag